Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sara Khosrowjerdi"'
Autor:
Victor Vaz, John V. Heymach, Natalie I. Vokes, Liam F. Spurr, Jacklynn V. Egger, Biagio Ricciuti, Subba R. Digumarthy, Andrew D. Cherniack, Ferdinandos Skoulidis, Andrew J. Plodkowski, Michael Y. Tolstorukov, Xinan Wang, Jessica J. Lin, Nuno Vaz, Jianjun Zhang, Gonzalo Recondo, Deepti Venkatraman, Justin F. Gainor, David A. Barbie, Giuseppe Lamberti, Mehmet Altan, Yvonne Y. Li, Lingzhi Hong, Lynette M. Sholl, Hye Sun Park, Kathryn C. Arbour, Matthew D. Hellmann, Mark M. Awad, Mizuki Nishino, Amir Vajdi, Joao Victor Machado Alessi, Hira Rizvi, Sara Khosrowjerdi
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 17(3)
Introduction STK11 and KEAP1 mutations (STK11 mutant [STK11MUT] and KEAP1MUT) are among the most often mutated genes in lung adenocarcinoma (LUAD). Although STK11MUT has been associated with resistance to programmed death-(ligand)1 (PD-[L]1) inhibiti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa8c672821b59caccc94036f34a3ec4b
https://pubmed.ncbi.nlm.nih.gov/35623684
https://pubmed.ncbi.nlm.nih.gov/35623684
Autor:
Keenan M. Mahan, Crystal M. North, Justin S. Becker, Andrew Z. Fenves, Bryan D. Hayes, Daniel S. Sinden, Guibenson Hyppolite, Dana A Stearns, Sara Khosrowjerdi
Publikováno v:
The Journal of Emergency Medicine
Background Hydroxychloroquine (HCQ) poisoning is a life-threatening but treatable toxic ingestion. The scale of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19) and the controversial suggestion that HCQ is a treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70bd9dc3b70a85df4509ef6025232b92
Autor:
Justin F. Gainor, Christine A. Lydon, S. Subegdjo, Mark M. Awad, Hira Rizvi, Sasha Kravets, Matthew D. Hellmann, E. Jimenez Alguilar, Sara Khosrowjerdi, Anika E. Adeni
Publikováno v:
Journal of Thoracic Oncology. 13:S367-S368
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::04357ea8cf8d37cfad59a4f43381630b
https://doi.org/10.1016/j.jtho.2018.08.343
https://doi.org/10.1016/j.jtho.2018.08.343
Autor:
Yvonne Y. Li, Mizuki Nishino, Gonzalo Recondo, Andrew J. Plodkowski, Justin F. Gainor, Kathryn C. Arbour, Matthew D. Hellmann, Amir Vajdi Hoojghan, Biagio Ricciuti, Subba R. Digumarthy, Andrew D. Cherniack, Mark M. Awad, Deepti Venkatraman, Jacklynn V. Egger, Natalie I. Vokes, Jessica J. Lin, Lynette M. Sholl, Giuseppe Lamberti, Sara Khosrowjerdi, Hira Rizvi
Publikováno v:
Web of Science
e15113 Background: STK11 mutations ( STK11m) have been associated with resistance to ICI in KRAS-mutant ( KRASm) NSCLC. Whether STK11m status also impacts clinical outcomes to ICI in KRAS wild-type (wt) NSCLC is unknown. Methods: We analyzed clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffe3677c28c4370128ae8eb1199b0c74
https://publons.com/wos-op/publon/55969013/
https://publons.com/wos-op/publon/55969013/
